More

    Europe Markets

    Neparvis | European Medicines Agency (EMA)

    OverviewNeparvis is a heart medicine used in adults with chronic (long-term) heart failure who have symptoms of the disease and reduced ejection fraction...
    Europe Markets

    GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.)

    OverviewBudesonide/Formoterol Teva Pharma B.V. is a medicine used for the treatment of asthma in adults for whom a combination product is considered appropriate....
    Europe Markets

    Vyndaqel | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Vyndaqel. It explains how the Committee for Medicinal Products for Human...
    Europe Markets

    Spexotras | European Medicines Agency (EMA)

    OverviewSpexotras is a cancer medicine used to treat children aged 1 year and older with glioma (a type of brain tumour). It is...
    Europe Markets

    Iclusig | European Medicines Agency (EMA)

    OverviewIclusig is a cancer medicine that contains the active substance ponatinib. It is used to treat adults with the following types of leukaemia...
    Europe Markets

    Ebvallo | European Medicines Agency (EMA)

    OverviewEbvallo is a medicine used to treat adults and children from 2 years of age who, after receiving an organ- or a bone...
    Europe Markets

    Erbitux | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Erbitux. It explains how the Committee for Medicinal Products for Human...
    Europe Markets

    Blenrep | European Medicines Agency (EMA)

    OverviewThe conditional marketing authorisation for Blenrep has not been renewed by the European Commission. ...
    Europe Markets

    Pregabalin Sandoz | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Pregabalin Sandoz. It explains how the Agency assessed the medicine to...
    Europe Markets

    Thyrogen | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Thyrogen. It explains how the Committee for Medicinal Products for Human...
    Europe Markets

    Memantine Mylan | European Medicines Agency (EMA)

    OverviewThis is a summary of the European public assessment report (EPAR) for Memantine Mylan. It explains how the Agency assessed the medicine to...
    Europe Markets

    Sapropterin Dipharma | European Medicines Agency (EMA)

    OverviewSapropterin Dipharma is a medicine that is used to treat high blood levels of phenylalanine in adults and children of all ages with...
    Europe Markets

    Saxenda | European Medicines Agency (EMA)

    OverviewSaxenda is a medicine used along with diet and increased physical activity to help manage weight in:adults who have obesity (BMI of 30...
    Europe Markets

    Tuznue | European Medicines Agency (EMA)

    OverviewTuznue is a cancer medicine used to treat the following conditions:early breast cancer (when the cancer has spread within the breast or to...
    Europe Markets

    Frequently asked questions | European Medicines Agency (EMA)

    A general 'Site-wide search' bar is featured at the top right of every page on the EMA website. It allows you to perform...
    Europe Markets

    Fabhalta | European Medicines Agency (EMA)

    OverviewFabhalta is a medicine used in adults with paroxysmal nocturnal haemoglobinuria (PNH) to treat haemolytic anaemia.PNH is a disease in which the excessive...
    Europe Markets
    1...678...16Page 7 of 16

    © 2025 Liberte